Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;42(4):545-51.
doi: 10.1007/s11239-016-1398-4.

Persistent neutrophilia is a marker for an increased risk of venous thrombosis

Margarita Kushnir  1 , Hillel W Cohen  2 , Henny H Billett  3
Affiliations

Persistent neutrophilia is a marker for an increased risk of venous thrombosis

Margarita Kushnir et al. J Thromb Thrombolysis. 2016 Nov.

Abstract

In patients with cancer and myeloproliferative disorders, leukocytosis has been associated with an increased venous thromboembolic (VTE) risk. Our goal was to determine whether persistent neutrophilia (PN), not associated with known causes such as malignancies, infections or steroids, is independently associated with VTE. All adult patients with >3 outpatient complete blood counts (CBCs) within 3 years were included. PN was defined as having an absolute neutrophil count >95 % (>2SD) of the population (≥7.8 × 10(9)/L) on at least three CBCs, at least 2 months apart. Separate analyses for neutrophil counts ≥9 × 10(9)/L and ≥10 × 10(9)/L were also performed. Blood counts from inpatients were excluded. Primary outcome was diagnosis of VTE, as determined by ICD-9 codes. Odds ratios were adjusted for diabetes, smoking, obesity, gender, and age. Charlson score was utilized as a morbidity measure. Data on 43,538 outpatients were collected. Although there was no association of VTE with neutrophil counts ≥7.8 × 10(9)/L, patients with ≥9.0 × 10(9)/L neutrophils were twice as likely to be diagnosed with VTE compared to those with normal neutrophil counts (OR 2.0, 95 % CI 1.3, 3.1; p = 0.003). Patients with neutrophil counts ≥10.0 × 10(9)/L were at an even higher risk (OR 2.3, 95 % CI 1.2, 4.8; p = 0.019). Charlson scores significantly modified this risk when incorporated into analysis. Elevated neutrophil counts are associated with an increased risk of venous thrombosis even when they are not due to cancer, infection or steroids. In patients with significant comorbidities, neutrophilia may be a marker of VTE risk.

Keywords: Diabetes; Leukocytosis; Neutrophilia; Obesity; Venous thrombosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):147-51 - PubMed
    1. Med Clin (Barc). 2015 Mar 15;144(6):247-53 - PubMed
    1. J Thromb Haemost. 2011 Sep;9(9):1791-4 - PubMed
    1. Best Pract Res Clin Haematol. 2014 Jun;27(2):121-7 - PubMed
    1. J Thromb Haemost. 2014 Jun;12(6):860-70 - PubMed

LinkOut - more resources